Physician profile
Sangeetha M Kodoth
NPI 1063465573
$7,774.26
in general payments reported to CMS, 2019-2025
33 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $636 · 2021: $1,088 · 2022: $1,338 · 2023: $1,130 · 2024: $1,272 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,944 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,944.05 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,109.59 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $986.70 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Csl Behring | $940.80 | 2019-2025 | Hizentra, Haegarda, Andembry |
| Glaxosmithkline, LLC. | $833.58 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $646.11 | 2020-2025 | Takhzyro, Cuvitru, Eohilia |
| Genentech USA, INC. | $464.82 | 2019-2025 | Xolair |
| Genzyme Corporation | $445.51 | 2021-2025 | |
| Hospira, INC. | $355.22 | 2020-2024 | |
| Grifols USA, LLC | $325.14 | 2019-2025 | Xembify |
| Amgen INC. | $163.27 | 2022-2024 | Tezspire |
| Novartis Pharmaceuticals Corporation | $160.41 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.89 | 2021-2022 | |
| Biocryst US Sales Co., LLC | $131.12 | 2022-2025 | Orladeyo |
| Teva Pharmaceuticals USA, INC. | $122.76 | 2021-2023 | Airduo Digihaler |
| Optinose US, INC. | $112.92 | 2024-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $75.00 | 2022 | |
| Horizon Therapeutics Plc | $73.67 | 2019-2021 | |
| Shire North American Group INC | $73.54 | 2019 | |
| Ionis Pharmaceuticals, INC. | $62.83 | 2025 | Dawnzera |
| Pfizer INC. | $62.48 | 2020-2024 | |
| Ars Pharmaceuticals Operations, INC. | $57.37 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Hikma Pharmaceuticals USA | $46.07 | 2023-2025 | Ryaltris |
| Phadia US INC. | $45.31 | 2021-2022 | |
| Octapharma USA, INC. | $44.17 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $41.08 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.32 | 2025 | Lifevest |
| Paratek Pharmaceuticals, INC. | $36.32 | 2025 | Xhance |
| Kaleo, INC. | $32.49 | 2020-2022 | |
| Circassia INC. | $30.59 | 2019 | |
| Alk-Abello, INC | $22.32 | 2021 | |
| Biocryst Pharmaceuticals, INC. | $15.11 | 2020 | |
| Blueprint Medicines Corporation | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sangeetha Kodoth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.